ImmunityBio Stock Soaring Today: Key Catalysts Unpacked
ImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
New investors often wonder what to ask financial advisors. Discover essential questions that can lead to tailored advice and successful investing.
28,527 articlesImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
C3.AI has faced a rough run, leaving investors wondering if a comeback is possible. This article breaks down the fact...
A thorough look at Novanta's Q1 2026 results and what they signal for novanta (novt) 2026 earnings. We break down rev...
A fresh AI-driven rally has investors buzzing about Alphabet. This article breaks down why alphabet stock popped toda...
A legendary investor speculates SpaceX could reach $30 trillion by 2040. This piece breaks down what that would requi...
On March 2, energy and defense names spearheaded gains as oil jumped, while travel and leisure stocks softened. This ...
C3.AI reports two consecutive quarterly revenue declines, forcing investors to reassess its enterprise AI strategy as...
NVIDIA is set to report quarterly results as investors wrestle with hype around AI. Analysts forecast strong growth b...
Global markets sold off after leaders offered little concrete trade progress. Investors warn that day one of talks ma...
SoFi posted stronger Q1 2026 results, but the stock remains depressed as investors weigh the path to sustained profit...
As markets shift in 2026, Netflix and Disney face different risk-reward profiles. This analysis weighs dividends, val...
ASML is set to report Q2 results on July 15, 2026, with investors eyeing an reaffirmed or higher FY2026 revenue targe...